119
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of Red Cell Index and Adverse Hospitalization Outcomes in Chronic Obstructive Pulmonary Disease Patients with Acute Exacerbation: A Retrospective Cohort Study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 2263-2275 | Received 13 May 2022, Accepted 22 Aug 2022, Published online: 15 Sep 2022

References

  • World Health Organization. World Health Organization (WHO) Website. Available from: https://www.who.int/zh/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed January 1, 2022.
  • World Health Organization. World health statistics 2021: a visual summary. Available from: https://www.who.int/data/stories/world-health-statistics-2021-a-visual-summary. Accessed February 1, 2022.
  • Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397–412. doi:10.1183/09031936.06.00025805
  • Fitzmaurice C, Abate D, Abbasi N, Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749–1768. doi:10.1001/jamaoncol.2019.2996
  • Global Initiative for Chronic Obstructive Lung. Global strategy for diagnosis, management, and prevention of COPD; 2022. Available from: https://goldcopd.org/. Accessed January 1, 2022.
  • Nguyen PL, Uddin MM, Mir T, et al. Trends in incidence, and mortality of acute exacerbation of chronic obstructive pulmonary disease in the United States Emergency Department (2010–2018). COPD. 2021;18(5):567–575. doi:10.1080/15412555.2021.1979500
  • Hage JJ, Brinkman RJ. Andreas Vesalius’ understanding of pulmonary ventilation. Respir Physiol Neurobiol. 2016;231:37–44. doi:10.1016/j.resp.2016.05.015
  • Elojeimy S, Cruite I, Bowen S, Zeng J, Vesselle H. Overview of the novel and improved pulmonary ventilation-perfusion imaging applications in the Era of SPECT/CT. AJR Am J Roentgenol. 2016;207(6):1307–1315. doi:10.2214/AJR.15.15071
  • Baird G. Preanalytical considerations in blood gas analysis. Biochem Med (Zagreb). 2013;23(1):19–27. doi:10.11613/BM.2013.005
  • Xu L, Chen Y, Xie Z, et al. High hemoglobin is associated with increased in-hospital death in patients with chronic obstructive pulmonary disease and chronic kidney disease: a retrospective multicenter population-based study. BMC Pulm Med. 2019;19(1):174. doi:10.1186/s12890-019-0933-4
  • Guang Y, Jie Z, Feng D, Hui L. Surrogate scale for evaluating respiratory function based on complete blood count parameters. J Clin Lab Anal. 2018;32(5):e22385. doi:10.1002/jcla.22385
  • Gao S, Chen J, Xie J, Wang J. The effects of BAFF on T lymphocytes in chronic obstructive pulmonary disease. Respir Res. 2020;21(1):66. doi:10.1186/s12931-020-01333-z
  • Kornerup KN, Page CP. The role of platelets in the pathophysiology of asthma. Platelets. 2007;18(5):319–328. doi:10.1080/09537100701230436
  • Huang Y, Wang J, Shen J, et al. Relationship of red cell index with the severity of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2021;16:825–834. doi:10.2147/COPD.S292666
  • Rivas-Ruiz F, Redondo M, Gonzalez N, et al. Appropriateness of diagnostic effort in hospital emergency room attention for episodes of COPD exacerbation. J Eval Clin Pract. 2015;21(5):848–854. doi:10.1111/jep.12390
  • Lu FY, Chen R, Li N, et al. Neutrophil-to-lymphocyte ratio predicts clinical outcome of severe acute exacerbation of COPD in frequent exacerbators. Int J Chron Obstruct Pulmon Dis. 2021;16:341–349. doi:10.2147/COPD.S290422
  • Romskaug R, Skovlund E, Straand J, et al. Effect of clinical geriatric assessments and collaborative medication reviews by geriatrician and family physician for improving health-related quality of life in home-dwelling older patients receiving polypharmacy: a cluster randomized clinical trial. JAMA Intern Med. 2020;180(2):181–189. doi:10.1001/jamainternmed.2019.5096
  • White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–399. doi:10.1002/sim.4067
  • Austin PC, White IR, Lee DS, van Buuren S. Missing data in clinical research: a tutorial on multiple imputation. Can J Cardiol. 2021;37(9):1322–1331. doi:10.1016/j.cjca.2020.11.010
  • Beesley LJ, Bondarenko I, Elliot MR, Kurian AW, Katz SJ, Taylor JM. Multiple imputation with missing data indicators. Stat Methods Med Res. 2021;30(12):2685–2700. doi:10.1177/09622802211047346
  • Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007;29(5):923–929. doi:10.1183/09031936.00137106
  • Vasquez A, Logomarsino JV. Anemia in chronic obstructive pulmonary disease and the potential role of iron deficiency. COPD. 2016;13(1):100–109. doi:10.3109/15412555.2015.1043519
  • Vlahakos V, Marathias K, Lionaki S, Loukides S, Zakynthinos S, Vlahakos D. The paradigm shift from polycythemia to anemia in COPD: the critical role of the renin-angiotensin system inhibitors. Expert Rev Respir Med. 2022;16(4):391–398. doi:10.1080/17476348.2022.2045958
  • Trudzinski FC, Jorres RA, Alter P, et al. Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: results from COSYCONET. Sci Rep. 2020;10(1):10544. doi:10.1038/s41598-020-67197-x
  • Sahin F, Kosar AF, Aslan AF, Yigitbas B, Uslu B. Serum biomarkers in patients with stable and acute exacerbation of chronic obstructive pulmonary disease: a comparative study. J Med Biochem. 2019;38(4):503–511. doi:10.2478/jomb-2018-0050
  • Cao Y, Xing Z, Long H, et al. Predictors of mortality in COPD exacerbation cases presenting to the respiratory intensive care unit. Respir Res. 2021;22(1):77. doi:10.1186/s12931-021-01657-4
  • Liu J, Liu J, Zou Y. Relationship between neutrophil-lymphocyte ratio and short-term prognosis in the chronic obstructive pulmonary patients with acute exacerbation. Biosci Rep. 2019;39:5. doi:10.1042/BSR20190675
  • Acanfora D, Scicchitano P, Carone M, et al. Relative lymphocyte count as an indicator of 3-year mortality in elderly people with severe COPD. BMC Pulm Med. 2018;18(1):116. doi:10.1186/s12890-018-0685-6
  • Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1385–1395. doi:10.3945/ajcn.111.023499
  • Rahimi-Rad MH, Soltani S, Rabieepour M, Rahimirad S. Thrombocytopenia as a marker of outcome in patients with acute exacerbation of chronic obstructive pulmonary disease. Pneumonol Alergol Pol. 2015;83(5):348–351. doi:10.5603/PiAP.2015.0056
  • Kelly AM, Holdgate A, Keijzers G, et al. Epidemiology, treatment, disposition and outcome of patients with acute exacerbation of COPD presenting to emergency departments in Australia and South East Asia: an AANZDEM study. Respirology. 2018;23(7):681–686. doi:10.1111/resp.13259
  • Grabicki M, Kuznar-Kaminska B, Rubinsztajn R, et al. COPD course and comorbidities: are there gender differences? Adv Exp Med Biol. 2019;1113:43–51. doi:10.1007/5584_2018_160
  • Souto-Miranda S, van ‘t Hul AJ, Vaes AW. Differences in pulmonary and extra-pulmonary traits between women and men with chronic obstructive pulmonary disease. J Clin Med. 2022;11:13. doi:10.3390/jcm11133680